MDxHealth Receives Additional Nasdaq Letter Over Minimum Bid Violation; Time Granted Till Dec ’26

Also Read

• Conflicting Views on Immigration in South Africa
• Incyte’s Q2 Financial Outlook: Will Strong Sales Fuel a Breakthrough-Heavy Drug Portfolio?
• Tripoli Protests Escalate as Prolonged Power Outages Fuel Public Anger
• Analyst Expects Andy Jassy to Lift Amazon’s 2026 Capex Guidance Ahead of July 30 Earnings